Alex Nichols is the founder of Mythic Therapeutics. Mythic Therapeutics has raised $130M in total funding. Latest round: Series B.
Alex Nichols, PhD, co-founded Mythic Therapeutics in 2017 to develop antibody-drug conjugates (ADCs) for cancer treatment. He bootstrapped the company initially and later led seed financing and a Series A round. He is currently the Chief Strategy and Operations Officer at enGene Holdings.
Full founder directory · Investor directory · Company funding database · Fundraising library